Collaborative Human-Agent Protocol (CHAP) Proposed for Multi-Agent, Multi-Human AI Systems
A team of researchers has published a preprint introducing the Collaborative Human-Agent Protocol (CHAP), a proposed standard for structuring how humans and AI agents work together in complex, multi-agent deployments. The protocol addresses a gap left by existing standards MCP and A2A, which cover tool access and agent-to-agent communication but not the shared workspace where humans and agents perform accountable work. CHAP aims to make human oversight actions—such as edits, approvals, and handoffs—formally recorded, auditable, and cryptographically verifiable.
Published on arXiv on June 8, 2026, the paper introduces CHAP as a response to the growing deployment of foundation models in high-stakes operational roles involving customers, clinical decisions, contracts, and code. The authors argue that current multi-human, multi-agent collaborations lack a well-defined technical surface for accountability, with human interventions often disappearing into chat threads or ticket comments. CHAP defines a core set of primitives—workspaces, participants, tasks, artefacts, and an append-only evidence log—along with composable profiles for review, routing, deliberation, handoffs, identity, digital signatures, and audit. A key design goal is making human override and approval actions into structured, non-repudiable signed events that can be replayed or audited years later. The protocol is positioned as complementary to MCP and A2A rather than a replacement, filling the specific gap of human-agent collaboration accountability. A reference implementation, conformance suite, and worked examples are publicly available alongside the specification.
What's missing
As a preprint, CHAP has not undergone peer review. The paper does not report empirical evaluations of the protocol in real production deployments, leaving open questions about adoption friction, performance overhead of the append-only evidence log at scale, and how the protocol handles adversarial or Byzantine participants in multi-agent settings. Governance and standardization pathway (e.g., which body, if any, would ratify CHAP) is not addressed.
What different sources said
- arXiv cs.AICenter
Collaborative Human-Agent Protocol (CHAP)
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.